Acutus Medical Completes $75 Million Series C Financing Round

On March 22, 2016, Acutus Medical, an electrophysiology company committed to transforming how electrophysiologists (EPs) image, diagnose, and treat complex arrhythmias, announced that it has closed a $75 million Series C round of financing. The all-equity financing round included new investors Deerfield Management Company, Xeraya Capital, and an undisclosed strategic investor, as well as existing investors Advent Life Sciences, OrbiMed, and GE Ventures. Wilson Sonsini Goodrich & Rosati represented Acutus Medical in the transaction.

The WSGR team that represented Acutus Medical included partner Scott Murano and associates Eric Hsu and Jason Koo.

For more information, click here to read the company's press release.